BioCardia, Inc. (BCDA)
1.11
+0.03
(+2.78%)
USD |
NASDAQ |
Sep 08, 16:00
1.12
+0.01
(+0.90%)
Pre-Market: 20:00
BioCardia Market Cap : 16.63M for Sept. 8, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 08, 2026 | 16.63M |
| September 04, 2026 | 16.18M |
| September 03, 2026 | 16.33M |
| September 02, 2026 | 16.63M |
| September 01, 2026 | 16.48M |
| August 31, 2026 | 17.08M |
| August 28, 2026 | 17.23M |
| August 27, 2026 | 17.53M |
| August 26, 2026 | 17.83M |
| August 25, 2026 | 16.93M |
| August 24, 2026 | 15.88M |
| August 21, 2026 | 15.13M |
| August 20, 2026 | 14.49M |
| August 19, 2026 | 14.85M |
| August 18, 2026 | 14.62M |
| August 17, 2026 | 14.09M |
| August 14, 2026 | 14.59M |
| August 13, 2026 | 13.92M |
| August 12, 2026 | 13.19M |
| August 11, 2026 | 13.97M |
| August 10, 2026 | 14.49M |
| August 07, 2026 | 10.70M |
| August 06, 2026 | 10.39M |
| August 05, 2026 | 10.39M |
| August 04, 2026 | 9.958M |
| Date | Value |
|---|---|
| August 03, 2026 | 9.094M |
| July 31, 2026 | 9.017M |
| July 30, 2026 | 8.436M |
| July 29, 2026 | 8.465M |
| July 28, 2026 | 8.550M |
| July 27, 2026 | 8.843M |
| July 24, 2026 | 9.300M |
| July 23, 2026 | 9.901M |
| July 22, 2026 | 9.912M |
| July 21, 2026 | 10.08M |
| July 20, 2026 | 9.899M |
| July 17, 2026 | 9.035M |
| July 16, 2026 | 9.354M |
| July 15, 2026 | 9.586M |
| July 14, 2026 | 8.774M |
| July 13, 2026 | 9.958M |
| July 10, 2026 | 10.01M |
| July 09, 2026 | 9.763M |
| July 08, 2026 | 10.56M |
| July 07, 2026 | 11.10M |
| July 06, 2026 | 12.80M |
| July 02, 2026 | 13.13M |
| July 01, 2026 | 13.02M |
| June 30, 2026 | 13.57M |
| June 29, 2026 | 13.24M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Cytokinetics, Inc. | 10.46B |
| ACADIA Pharmaceuticals, Inc. | 4.747B |
| Alnylam Pharmaceuticals, Inc. | 34.78B |
| Anika Therapeutics, Inc. | 281.58M |
| Savara, Inc. | 1.136B |
Market Cap Related Metrics
| Price to Book Value | 6.160 |
| Price | 1.11 |
| Earnings Yield | -68.74% |